PHARMACEUTICALS
Aspen Pharmacare will review its infant milk formula business with options including a sale to a strategic partner, Africa's biggest generic drugmaker said on Monday. The unit, which has factories in New Zealand, South Africa and Mexico, follows the approval by the China Food and Drug Administration's registration of the company's baby milk formula brand, Alula.
This content is only available to subscribers.
Forgot your password? Click here
Don't have any login details?
Free Trial Access